Back

Prognostic value of quantitative SPECT/CT metrics in transthyretin amyloid cardiomyopathy

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Multimodality cardiac computed tomography and cardiovascular magnetic resonance in pericardial and myocardial disease Imaging of Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Gregorio Tersalvi

Mayo Clinic, Rochester (United States of America)

6 More presentations in this session

Presentation thumbnail
Characterising patients and lesions with plaque progression despite high-intensity LDL-C-lowering therapy: a multimodality serial intracoronary imaging study from the IBIS-4 and PACMAN-AMI trials
Doctor R. Kakizaki (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Multimodality pericardial phenotype on CT and CMR predicts treatment failure in inflammatory and constrictive pericardial syndromes
Doctor A. Tawfek (Cardiff, GB)
Presentation thumbnail
Diagnostic utility of spectral computed tomography in acute myocardial damage without obstructive coronary disease: the CADAMI-SPECTRAL study
Doctor C. Herrera (Salamanca, ES)
Abstract Slides Video
Presentation thumbnail
Border zone channel mass predicts ventricular arrhythmias independently of LVEF in ICD patients
Doctor J. Lubian Esplugues (Cadiz, ES)
Abstract Slides Video
Presentation thumbnail
Differential effects of Tafamidis on cardiac remodelling in transthyretin amyloid cardiomyopathy: evidence from contemporary imaging data
Doctor A. Jirjis (Sydney, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodality cardiac computed tomography and cardiovascular magnetic resonance in pericardial and myocardial disease

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Quantitative SPECT/CT for diagnosis of transthyretin amyloid cardiomyopathy: a pathology-based study
30 August 2025
thumbnail
Congress Presentation
Prognostic significance of concomitant transthyretin cardiac amyloidosis and severe aortic stenosis: insights from a systematic review and meta-analysis
31 August 2025
thumbnail
Congress Presentation
Clinical implications of cardiac implantable electronic devices in ATTR cardiomyopathy
17 May 2025
thumbnail
Congress Presentation
Cardiovascular prognosis in stable patients with amyloidosis: a novel and simple risk score.
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources